VRTX ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/3/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)4.34
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)3.33B
Vertex Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Vertex Pharmaceuticals Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Vertex Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Vertex Pharmaceuticals Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Vertex Pharmaceuticals Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
VRTX ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง11/2/2026(Post-Market)
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)4.77
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)3.41B
VRTX FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)15.46844.44%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)12.00B8.90%
Vertex Pharmaceuticals Inc(VRTX) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/3/2026 | 06/2026 | 4.34/4.74 | 3.33B/3.23B | -8.49% | 3.09% |
| 5/4/2026 | 03/2026 | 4.06/4.31 | 2.99B/3.02B | -5.90% | -1.10% |
| 2/12/2026 | 12/2025 | 4.70/5.07 | 3.19B/3.18B | -7.42% | 0.45% |
| 11/3/2025 | 09/2025 | 4.24/4.56 | 3.08B/3.05B | -7.16% | 0.76% |
| 8/4/2025 | 06/2025 | 4.02/4.28 | 2.96B/2.91B | -6.07% | 2.04% |
| 5/5/2025 | 03/2025 | 2.52/4.29 | 2.77B/2.85B | -41.35% | -2.89% |
| 2/10/2025 | 12/2024 | 3.55/4.03 | 2.91B/2.78B | -11.85% | 4.73% |
| 11/4/2024 | 09/2024 | 4.05/4.14 | 2.77B/2.72B | -2.16% | 1.77% |